South New Jersey’s Largest Healthcare Provider
Incorporates AI Tech as Part of Multifaceted Campaign Against Gun
Violence
Evolv Technology (NASDAQ: EVLV), the leading security technology
company pioneering AI-based screening to create safer experiences,
today announced its partnership with Virtua Health, a
not-for-profit health system in New Jersey.
Virtua Health will use 14 Evolv Express® systems at five of its
hospitals and two of its health-and-wellness campuses. So far, the
weapons detection technology has been installed at five facilities.
Evolv Express uses sensor technology combined with AI to tell the
difference between many everyday metal items people carry in their
pockets and certain objects that pose a threat.
In a hospital, Evolv’s presence can alert visitors, patients and
staff that the hospital is committed to safety, which is
particularly important given the prevalence of violence in
healthcare settings. Healthcare workers are five times as likely to
suffer a workplace violence injury when compared to other
professionals.
Evolv Express has proven its immediate positive impact for
Evolv’s healthcare customers. Windsor Regional Hospital in Windsor,
Ontario, just across the border from Detroit, reported that Evolv
detected more than 2,000 weapons at the emergency department in
less than six months. After installing Evolv Express in its lobby
last October, The Hospital of the University of Pennsylvania
reported that the system prevented more than 300 weapons from
entering the facility in its first three months in use.
Virtua Health learned about Evolv from the Philadelphia
Phillies, one of a number of professional baseball teams that
partner with Evolv for weapons detection at ballpark entrances.
“Actions speak louder than words and partnering with Evolv
demonstrates to our staff, patients and community that violence
prevention is one of our top priorities because the safety of those
inside our hospitals is paramount,” said Gregory Pease, assistant
vice president of security and outpatient services for Virtua
Health. “As a former police officer, I’ve seen a number of violence
mitigation strategies, and I trust Evolv. The results speak for
themselves.”
Virtua Health is at the forefront of gun violence prevention in
southern New Jersey. The health system co-sponsored a statewide gun
buyback initiative a few years ago, and works with the community to
support gun safety education. In Evolv’s second annual Gun Violence
in America survey, 36% of Americans said they believe they or
someone they love are extremely/likely to encounter an active
shooter in their lifetime.
“People have enough on their minds when they’re in a hospital,
and whether or not they are safe in that environment should not be
a concern,” said Jay Muelhoefer, chief commercial officer for Evolv
Technology. “Evolv is proud to partner with Virtua Health to
elevate safety and allow the focus in that setting to be on
improved health outcomes.”
Evolv’s more than 4,500 systems deployed worldwide help secure
leading theme parks, performing arts centers, casinos, places of
worship, sports venues and schools, in addition to hospitals.
About Evolv Technology
Evolv Technology (NASDAQ: EVLV) is transforming human security
to make a safer, faster, and better experience for the world’s most
iconic venues and companies as well as schools, hospitals, and
public spaces, using industry leading artificial intelligence
(AI)-powered screening and analytics. Its mission is to transform
security to create a safer world to work, learn, and play. Evolv
has digitally transformed the gateways in places where people
gather by enabling seamless integration combined with powerful
analytics and insights. Evolv’s advanced systems have scanned more
than a billion people since 2019. Evolv has been awarded the U.S.
Department of Homeland Security (DHS) SAFETY Act Designation as a
Qualified Anti-Terrorism Technology (QATT) as well as the Security
Industry Association (SIA) New Products and Solutions (NPS) Award
in the Law Enforcement/Public Safety/Guarding Systems category, as
well as Sport Business Journal’s (SBJ) awards for “Best In Fan
Experience Technology” and “Best In Sports Technology”. Evolv®,
Evolv Express®, Evolv Insights®, Evolv Cortex AI®, and Evolv Visual
Gun Detection™ are registered trademarks or trademarks of Evolv
Technologies, Inc. in the United States and other jurisdictions.
For more information, visit https://evolvtechnology.com.
Forward-looking Statements
Certain statements in this press release may constitute
“forward-looking” statements and information, within the meaning of
Section 27A of the Securities Act of 1933, Section 21E of the
Securities Exchange Act of 1934, and the safe harbor provisions of
the U.S. Private Securities Litigation Reform Act of 1995 that
relate to our current expectations and views of future events. In
some cases, these forward-looking statements can be identified by
words or phrases such as “may,” “will,” “expect,” “anticipate,”
“aim,” “estimate,” “intend,” “plan,” “believe,” “potential,”
“continue,” “is/are likely to” or other similar expressions. These
forward-looking statements are subject to risks, uncertainties and
assumptions, some of which are beyond our control. In addition,
these forward-looking statements reflect our current views with
respect to future events or our Company’s performance and are not a
guarantee of future performance. Actual outcomes may differ
materially from the information contained in the forward-looking
statements as a result of a number of factors, including, without
limitation, the risk factors set forth in our Annual Report on Form
10-K for the year ended on December 31, 2023, that was filed with
the SEC on February 29, 2024, as may be updated in other filings we
make with the SEC, including our Quarterly Report on Form 10-Q for
the quarter ended on March 31, 2024 that was filed with the SEC on
May 9, 2024. These statements reflect management’s current
expectations regarding future events and operating performance and
speak only as of the date of this press release. You should not put
undue reliance on any forward-looking statements. Although we
believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee that future results,
levels of activity, performance and events and circumstances
reflected in the forward-looking statements will be achieved or
will occur. Except as required by law, we undertake no obligation
to update or revise publicly any forward-looking statements,
whether as a result of new information, future events or otherwise,
after the date on which the statements are made or to reflect the
occurrence of unanticipated events.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240521908664/en/
Media Contact: Alexandra Smith Ozerkis
aozerkis@evolvtechnology.com Investor Contact: Brian Norris
bnorris@evolvtechnology.com
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Dec 2024 to Dec 2024
Evolv Technologies (NASDAQ:EVLV)
Historical Stock Chart
From Dec 2023 to Dec 2024